Hedge Fund Hits 'Ridiculous' Horizon Patent With AIA Review
Hedge fund manager Kyle Bass, whose America Invents Act reviews of drug patents are under scrutiny by Congress, filed a new petition Thursday taking aim at a patent on Horizon Pharma...To view the full article, register now.
Already a subscriber? Click here to view full article